Significantly, these vesicles demonstrated the ability to diminish BMP5 signaling and counteract the effects of TGF-β on epithelial-to-mesenchymal transition (EMT), thereby restoring the prostate epithelial states in a clinically relevant BPH model derived from human BPH tissues. Here, TGFB1 is linked to benign prostatic hyperplasia.